IHRE AUFGABEN: Crafting proactive, patient-centric RM strategies tailored to designated compounds.
Overseeing and executing all PV activities pertinent to assigned drugs, encompassing database setup, continual safety monitoring, and addressing safety concerns.
Engaging in cross-functional collaboration with departments such as Clinical Development and Global Patient Engagement to devise patient-centric benefit-risk evaluations for developmental compounds.
Collaborating with Global Epidemiology and Medical Affairs to design safety-oriented post-authorization studies.
Analyzing clinical trial safety data for incorporation into clinical trial reports and regulatory submissions.
Providing medical-scientific insights into regulatory documents, including PSURs, DSURs, RMPs, and Clinical Overview Statements.
Chair multidisciplinary Benefit Risk Teams Keeping senior management apprised of the safety profile of designated drugs and suggesting PV/RM actions
IHR PROFIL: Medical degree (ideally with specialist education in psychiatry) with clinical and/or clinical research experience in the according therapeutic area.
Proficient knowledge in pharmacovigilance (PV) and a comprehensive understanding of PV regulations in major markets.
Experience in clinical development and involvement in regulatory submissions would be advantageous.
Excellent medical-scientific understanding of your indicational area(s) In-depth understanding of the pharmaceutical industry, future trends and developments in pharmacovigilance Practical understanding of PV regulation in major markets and respective need for compliance
Strong interpersonal and communication skills.
Strong ethical sense coupled with a focus on quality and patient safety.
Excellent English language skills, both written and verbal.